- Nafenopin
-
Nafenopin 2-Methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acidIdentifiers CAS number 3771-19-5 PubChem 19592 ChemSpider 18456 KEGG C11371 Jmol-3D images Image 1 - O=C(O)C(Oc1ccc(cc1)C3c2ccccc2CCC3)(C)C
- InChI=StdInChI=1S/C20H22O3/c1-20(2,19(21)22)23-16-12-10-15(11-13-16)18-9-5-7-14-6-3-4-8-17(14)18/h3-4,6,8,10-13,18H,5,7,9H2,1-2H3,(H,21,22)
Key: XJGBDJOMWKAZJS-UHFFFAOYSA-N
InChI=1S/C20H22O3/c1-20(2,19(21)22)23-16-12-10-15(11-13-16)18-9-5-7-14-6-3-4-8-17(14)18/h3-4,6,8,10-13,18H,5,7,9H2,1-2H3,(H,21,22)
InChI=1S/C20H22O3/c1-20(2,19(21)22)23-16-12-10-15(11-13-16)18-9-5-7-14-6-3-4-8-17(14)18/h3-4,6,8,10-13,18H,5,7,9H2,1-2H3,(H,21,22)
Key: XJGBDJOMWKAZJS-UHFFFAOYSA-N
Properties Molecular formula C20H22O3 Molar mass 310.39 g mol−1 Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox references Nafenopin is a hypolipidemic agent.
Synthesis
Nafenopin can be prepared from 1-tetralinol:[1]
References
- ^ R. Sarges, German Patent DE 2018135 (1970); Chem. Abstr., 74: 22,601b (1971).
Lipid modifying agents (C10) GI tract Ezetimibe • SCH-48461Liver Simvastatin# • Atorvastatin • Fluvastatin • Lovastatin • Mevastatin • Pitavastatin • Pravastatin • Rosuvastatin • Cerivastatin‡Blood vessels CETP inhibitors (HDL)Combinations Other Dextrothyroxine • Probucol • Tiadenol • Benfluorex • Meglutol • Omega-3-triglycerides • Magnesium pyridoxal 5-phosphate glutamate • Policosanol • Lapaquistat§ • Alipogene tiparvovecCategories:- Hypolipidemic agents
- Tetralins
- Phenol ethers
Wikimedia Foundation. 2010.